All-trans-retinoic acid decreases vein graft intimal hyperplasia and matrix metalloproteinase activity in vivo

被引:29
作者
Leville, CD [1 ]
Dassow, MS [1 ]
Seabrook, GR [1 ]
Jean-Claude, JM [1 ]
Towne, JB [1 ]
Cambria, RA [1 ]
机构
[1] Med Coll Wisconsin, Div Vasc Surg, Milwaukee, WI 53226 USA
关键词
vein graft; intimal hyperplasia; metalloproteinase; retinoids;
D O I
10.1006/jsre.2000.5887
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. Development of vein graft intimal hyperplasia has been associated with increased activity of matrix metalloproteinases (MMPs). All-trans-retinoic acid (atRA) decreases expression and activity of MMPs in tissue culture and has decreased intimal hyperplasia following arterial balloon catheter injury, We examined the effect of oral administration of atRA on intimal hyperplasia and MMP expression in an animal model of vein bypass grafting. Materials and methods. Interposition jugular vein bypass grafts were placed in the carotid artery of New Zealand white rabbits. Animals received either atRA (10 mg/kg/day) or vehicle (corn oil) for a period of 2 weeks. Retinoic acid serum levels were determined by HPLC, Intimal and medial areas were measured using morphometric analysis of perfusion-fixed vein graft specimens, and intimal thickness was calculated using circumferential measurements. Expression of MMP-2, MMP-9, and TIMP-1 in vein grafts and unoperated control veins was determined using Not-them analysis, and proteolytic activity was determined using substrate gel zymography. Results. Animals treated with atRA had significantly elevated serum levels of this compound and its metabolites. A decrease in intimal to medial ratio was noted after 28 days in vein grafts from treated animals (0.63 vs 0.88, P < 0.01), and a decrease in calculated intimal thickness was noted at 7 and 28 days. Expression of MMP-2 was decreased in treated animals 7 days following surgery, and expression of both MMP-2 and MMP-9 was decreased at 28 days. A decrease in proteolytic activity was noted on zymography at 68 kDa, 7 and 28 days following surgery in vein grafts from animals treated with atRA, corresponding with a decrease in the active form of MMP-2. Increased expression of TIMP-1 was noted in vein grafts from both the treated and the control groups, 7 and 28 days following graft placement. Conclusions. Oral administration of all-trans-retinoic acid resulted in decreased intimal hyperplasia in an animal model of vein bypass grafting This was associated with decreased expression and activity of MMP-2 in treated animals. (C) 2000 Academic Press.
引用
收藏
页码:183 / 190
页数:8
相关论文
共 20 条
[1]   Adenovirus-mediated gene transfer of the human tissue inhibitor of metalloproteinase-2 blocks vascular smooth muscle cell invasiveness in vitro and modulates neointimal development in vivo [J].
Cheng, L ;
Mantile, G ;
Pauly, R ;
Nater, C ;
Felici, A ;
Monticone, R ;
Bilato, C ;
Gluzband, YA ;
Crow, MT ;
Stetler-Stevenson, W ;
Capogrossi, MC .
CIRCULATION, 1998, 98 (20) :2195-2201
[2]   REGULATION OF THE EXPRESSION OF TISSUE INHIBITOR OF METALLOPROTEINASES AND COLLAGENASE BY RETINOIDS AND GLUCOCORTICOIDS IN HUMAN-FIBROBLASTS [J].
CLARK, SD ;
KOBAYASHI, DK ;
WELGUS, HG .
JOURNAL OF CLINICAL INVESTIGATION, 1987, 80 (05) :1280-1288
[3]   Overexpression of tissue inhibitor of matrix metalloproteinase-1 inhibits vascular smooth muscle cell functions in vitro and in vivo [J].
Forough, R ;
Koyama, N ;
Hasenstab, D ;
Lea, H ;
Clowes, M ;
Nikkari, ST ;
Clowes, AW .
CIRCULATION RESEARCH, 1996, 79 (04) :812-820
[4]   Adenovirus-mediated gene transfer of the human TIMP-1 gene inhibits smooth muscle cell migration and neointimal formation in human saphenous vein [J].
George, SJ ;
Johnson, JL ;
Angelini, GD ;
Newby, AC ;
Baker, AH .
HUMAN GENE THERAPY, 1998, 9 (06) :867-877
[5]  
Guerin E, 1997, J BIOL CHEM, V272, P11088
[6]   MODULATIONS OF ELASTIN EXPRESSION AND CELL-PROLIFERATION BY RETINOIDS IN CULTURED VASCULAR SMOOTH-MUSCLE CELLS [J].
HAYASHI, A ;
SUZUKI, T ;
TAJIMA, S .
JOURNAL OF BIOCHEMISTRY, 1995, 117 (01) :132-136
[7]   INHIBITION OF NITRIC-OXIDE SYNTHESIS IN VASCULAR SMOOTH-MUSCLE BY RETINOIDS [J].
HIROKAWA, K ;
OSHAUGHNESSY, KM ;
RAMRAKHA, P ;
WILKINS, MR .
BRITISH JOURNAL OF PHARMACOLOGY, 1994, 113 (04) :1448-1454
[8]  
HONG WK, 1984, RETINOIDS BIOL CHEM, P597
[9]   INDUCTION OF COLLAGENASE AND STROMELYSIN GENE-EXPRESSION BY MECHANICAL INJURY IN A VASCULAR SMOOTH MUSCLE-DERIVED CELL-LINE [J].
JAMES, TW ;
WAGNER, R ;
WHITE, LA ;
ZWOLAK, RM ;
BRINCKERHOFF, CE .
JOURNAL OF CELLULAR PHYSIOLOGY, 1993, 157 (02) :426-437
[10]  
LEVILLE CD, UNPUB MATRIX METALLO